GSK purchases Novartis Healthcare's vaccine business
GlaxoSmithKline Pharmaceuticals' (GSK) acquisition of Novartis Healthcare's vaccines business is complete, and GSK has sold its marketed oncology portfolio to Novartis India, while Novartis retains its influenza vaccine. Read More »